These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23739435)

  • 21. [Cavinton Comforte in the correction of vascular cognitive disorders].
    Shavlovskaya OA; Lokshina AB; Grishina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):61-65. PubMed ID: 30251979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cavinton in the treatment of ischemic cerebral stroke. Clinical and computerized-tomographic evaluation].
    Domzał T; Kozłowski P; Zaleska B
    Neurol Neurochir Pol; 1986; 20(3):234-40. PubMed ID: 3537828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
    Vaizova OE; Vengerovskiĭ AI; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effect of cavinton in chronic cerebral circulatory insufficiency].
    Burtsev EM; Tugutov AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(1):53-6. PubMed ID: 3984593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Betahistine in vertebrobasilar insufficiency.
    Kaźmierczak H; Pawlak-Osińska K; Kaźmierczak W
    Int Tinnitus J; 2004; 10(2):191-3. PubMed ID: 15732521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Omaron in the treatment of vertebrobasilar insufficiency].
    Lobzin SV; Bodrova TV; Vasilenko AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):40-3. PubMed ID: 19156085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relationship of indices of cerebral blood flow and reflex manifestations in patients with cervicogenic vertebrobasilar insufficiency].
    Kozar-Hurina OM
    Lik Sprava; 2013 Jun; (4):76-81. PubMed ID: 25095690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 34. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
    Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):31-4. PubMed ID: 16921716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
    Sešok S; Bolle N; Kobal J; Bucik V; Vodušek DB
    Psychiatr Danub; 2014 Sep; 26(3):239-48. PubMed ID: 25191771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vertebrobasilar infarcts and ischemia.
    Ishiyama G; Ishiyama A
    Otolaryngol Clin North Am; 2011 Apr; 44(2):415-35, ix-x. PubMed ID: 21474015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 39. [The safe use of cavinton forte in discirculatory encephalopathy].
    Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):55-7. PubMed ID: 16548377
    [No Abstract]   [Full Text] [Related]  

  • 40. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.